Respiri Limited (RSH.AX)
AUD 0.03
(-6.06%)
AUD 0.03
(-6.06%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 456.91 Thousand AUD | 547.8% |
| 2023 | 70.53 Thousand AUD | -72.2% |
| 2022 | 253.68 Thousand AUD | -6.07% |
| 2021 | 270.07 Thousand AUD | -87.47% |
| 2020 | 2.15 Million AUD | 110.02% |
| 2019 | 1.02 Million AUD | 19.13% |
| 2018 | 861.45 Thousand AUD | 4.34% |
| 2017 | 825.6 Thousand AUD | 21.81% |
| 2016 | 677.75 Thousand AUD | 621.11% |
| 2015 | 93.98 Thousand AUD | 395.33% |
| 2014 | 18.97 Thousand AUD | 74.74% |
| 2013 | 10.85 Thousand AUD | -16.26% |
| 2012 | 12.96 Thousand AUD | -96.09% |
| 2011 | 332.08 Thousand AUD | -4.71% |
| 2010 | 348.49 Thousand AUD | 54.59% |
| 2009 | 225.43 Thousand AUD | 125.0% |
| 2008 | 100.19 Thousand AUD | -69.26% |
| 2007 | 325.94 Thousand AUD | 870.91% |
| 2006 | 33.57 Thousand AUD | -35.33% |
| 2005 | 51.91 Thousand AUD | 0.0% |
| 2004 | - AUD | -100.0% |
| 2003 | 392.71 Thousand AUD | 670.04% |
| 2002 | 51 Thousand AUD | 4.08% |
| 2001 | 49 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 1.74 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 147.44 Thousand AUD | 0.0% |
| 2024 FY | 456.91 Thousand AUD | 547.8% |
| 2024 Q4 | 309.46 Thousand AUD | 0.0% |
| 2023 Q2 | 9843.00 AUD | 0.0% |
| 2023 Q4 | 60.69 Thousand AUD | 0.0% |
| 2023 FY | 70.53 Thousand AUD | -72.2% |
| 2022 Q2 | 140.49 Thousand AUD | 0.0% |
| 2022 FY | 253.68 Thousand AUD | -6.07% |
| 2022 Q4 | 113.19 Thousand AUD | 0.0% |
| 2021 Q4 | 145.17 Thousand AUD | 0.0% |
| 2021 Q2 | 124.89 Thousand AUD | 0.0% |
| 2021 FY | 270.07 Thousand AUD | -87.47% |
| 2020 FY | 2.15 Million AUD | 110.02% |
| 2020 Q2 | 2.15 Million AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2019 FY | 1.02 Million AUD | 19.13% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 Q2 | 1.02 Million AUD | 0.0% |
| 2018 FY | 861.45 Thousand AUD | 4.34% |
| 2018 Q2 | 865.15 Thousand AUD | 0.0% |
| 2018 Q4 | -3699.00 AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | 825.6 Thousand AUD | 0.0% |
| 2017 FY | 825.6 Thousand AUD | 21.81% |
| 2016 Q4 | 672.87 Thousand AUD | 0.0% |
| 2016 Q2 | 4876.00 AUD | 0.0% |
| 2016 FY | 677.75 Thousand AUD | 621.11% |
| 2015 Q4 | 93.49 Thousand AUD | 0.0% |
| 2015 FY | 93.98 Thousand AUD | 395.33% |
| 2015 Q2 | 495.00 AUD | 0.0% |
| 2014 Q2 | 12.32 Thousand AUD | 0.0% |
| 2014 FY | 18.97 Thousand AUD | 74.74% |
| 2014 Q4 | 6647.00 AUD | 0.0% |
| 2013 Q2 | 7761.00 AUD | 139.39% |
| 2013 Q1 | 3242.00 AUD | 0.0% |
| 2013 FY | 10.85 Thousand AUD | -16.26% |
| 2013 Q4 | 363.14 Thousand AUD | 13276.89% |
| 2013 Q3 | 2714.75 AUD | -65.02% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 FY | 12.96 Thousand AUD | -96.09% |
| 2012 Q2 | 3242.00 AUD | -96.09% |
| 2012 Q3 | 3242.00 AUD | 0.0% |
| 2012 Q1 | 83.02 Thousand AUD | 0.0% |
| 2011 Q2 | 83.02 Thousand AUD | -4.71% |
| 2011 Q1 | 87.12 Thousand AUD | 0.0% |
| 2011 FY | 332.08 Thousand AUD | -4.71% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 Q3 | 83.02 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 87.12 Thousand AUD | 0.0% |
| 2010 Q1 | 56.35 Thousand AUD | 0.0% |
| 2010 Q2 | 87.12 Thousand AUD | 54.59% |
| 2010 FY | 348.49 Thousand AUD | 54.59% |
| 2009 Q3 | 56.35 Thousand AUD | 0.0% |
| 2009 Q2 | 56.35 Thousand AUD | 125.01% |
| 2009 Q4 | - AUD | -100.0% |
| 2009 FY | 225.43 Thousand AUD | 125.0% |
| 2009 Q1 | 25.04 Thousand AUD | 0.0% |
| 2008 Q2 | 25.04 Thousand AUD | -32.83% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 FY | 100.19 Thousand AUD | -69.26% |
| 2008 Q1 | 37.28 Thousand AUD | 0.0% |
| 2008 Q3 | 25.04 Thousand AUD | 0.0% |
| 2007 Q1 | 8392.75 AUD | 0.0% |
| 2007 FY | 325.94 Thousand AUD | 870.91% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 Q3 | 37.28 Thousand AUD | 0.0% |
| 2007 Q2 | 37.28 Thousand AUD | 344.3% |
| 2006 Q3 | 8392.75 AUD | 0.0% |
| 2006 Q2 | 8392.75 AUD | -35.33% |
| 2006 FY | 33.57 Thousand AUD | -35.33% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q1 | 12.97 Thousand AUD | 0.0% |
| 2005 FY | 51.91 Thousand AUD | 0.0% |
| 2005 Q3 | 12.97 Thousand AUD | 0.0% |
| 2005 Q2 | 12.97 Thousand AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2004 Q1 | 725.00 AUD | 0.0% |
| 2004 Q2 | - AUD | -100.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | -100.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q1 | 12.68 Thousand AUD | 0.0% |
| 2003 Q2 | 725.00 AUD | -94.29% |
| 2003 Q3 | 725.00 AUD | 0.0% |
| 2003 FY | 392.71 Thousand AUD | 670.04% |
| 2002 Q3 | 12.68 Thousand AUD | 0.0% |
| 2002 Q1 | 12.25 Thousand AUD | 0.0% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 Q2 | 12.68 Thousand AUD | 3.57% |
| 2002 FY | 51 Thousand AUD | 4.08% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2001 Q3 | 12.25 Thousand AUD | 0.0% |
| 2001 Q2 | 12.25 Thousand AUD | 0.0% |
| 2001 FY | 49 Thousand AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1998 Q1 | 435.47 Thousand AUD | 0.0% |
| 1998 Q2 | - AUD | -100.0% |
| 1997 FY | 1.74 Million AUD | 0.0% |
| 1997 Q4 | 435.47 Thousand AUD | 0.0% |
| 1997 Q2 | 435.47 Thousand AUD | 0.0% |
| 1997 Q3 | 435.47 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 87.829% |
| Adherium Limited | 840.98 Thousand AUD | 45.669% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 99.279% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 88.819% |
| Anteris Technologies Ltd | 4.11 Million AUD | 88.886% |
| Control Bionics Limited | 5.12 Million AUD | 91.088% |
| CardieX Limited | 10.9 Million AUD | 95.81% |
| Compumedics Limited | 49.71 Million AUD | 99.081% |
| Cochlear Limited | 2.25 Billion AUD | 99.98% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 97.094% |
| Cyclopharm Limited | 27.13 Million AUD | 98.316% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 95.927% |
| Nova Eye Medical Limited | 23.32 Million AUD | 98.041% |
| HeraMED Limited | 402.89 Thousand AUD | -13.407% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | 25.774% |
| ImpediMed Limited | 10.31 Million AUD | 95.572% |
| InhaleRx Limited | 1.2 Million AUD | 62.052% |
| LBT Innovations Limited | 1.25 Million AUD | 63.621% |
| Micro-X Limited | 15.22 Million AUD | 96.998% |
| Neurotech International Limited | 1963.00 AUD | -23176.312% |
| OncoSil Medical Limited | 1.56 Million AUD | 70.811% |
| PolyNovo Limited | 103.19 Million AUD | 99.557% |
| SomnoMed Limited | 91.65 Million AUD | 99.501% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 93.111% |
| Uscom Limited | 3.72 Million AUD | 87.74% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 94.73% |